Back to News
Market Impact: 0.7

Google experiences deja vu as second monopoly trial begins in US

GOOGLGOOGMETA
Antitrust & CompetitionRegulation & LegislationLegal & LitigationTechnology & InnovationCompany FundamentalsCorporate EarningsArtificial IntelligenceMarket Technicals & Flows
Google experiences deja vu as second monopoly trial begins in US

Google is currently in a "remedy" trial concerning its digital advertising technology, which a US judge previously declared an illegal monopoly, with the Department of Justice advocating for a breakup of the ad tech business. Google argues such a divestiture would be disruptive and that evolving market dynamics, including AI, render the DOJ's proposals radical, while committing to appeal the initial monopoly finding. This high-stakes case, which targets a significant portion of Alphabet's $305 billion services revenue, is unfolding as the judge considers a recent, less severe remedy in Google's search monopoly trial that propelled Alphabet's market capitalization to $3 trillion.

Analysis

Alphabet is facing a critical remedy trial after its digital advertising technology, which underpins the majority of its $305 billion services division revenue, was declared an illegal monopoly. The Department of Justice is advocating for a structural breakup, seeking the forced sale of parts of Google's ad-tech business to restore market competition. However, this legal threat is significantly contextualized by the recent outcome of Google's separate search monopoly case, where a different judge opted for a far less severe remedy than the DOJ requested. That ruling, widely perceived as a 'slap on the wrist,' catalyzed a 20% rally in Alphabet's stock and pushed its market capitalization to $3 trillion. The judge in the current ad-tech case, Leonie Brinkema, has explicitly requested the parties address that precedent, suggesting it may be influential. Google is leveraging this by arguing that a breakup is 'radical' and unnecessary, citing market evolution driven by AI and competition from rivals like Meta Platforms, while also committing to appeal the initial monopoly finding regardless of the remedy's severity.